Log In
BCIQ
Print this Print this
 

Intranasal influenza vaccine, NasoVAX (Recombinant influenza vaccine)

  Manage Alerts
Collapse Summary General Information
Company Altimmune Inc.
DescriptionHemagglutinin (HA) gene delivery to nasal mucosa using a non-replicating adenovirus vector
Molecular Target
Mechanism of ActionGene therapy; Vaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza virus infection; Vaccinate against influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today